Adjuvant Therapy

Adjuvant therapy is a treatment done after the primary treatment, e.g. surgery, to decrease the chance of the ocular melanoma returning or spreading. It can also refer to any treatment used in addition to the primary form of treatment.

Currently, in ocular melanoma, all adjuvant treatments are in the clinical trial stage and nothing yet has been proven to show beneficial results.

The Cleveland Clinic's Arun Singh has an interesting paper from 2014 on the topic here.

And a more recent paper looks at the Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy.  Unfortunately, there was no increase in survival rate for the treated patients.